文献速递神经技术与安全MR

基于SHAP方法的影像组学-临床模型评估全脑放疗治疗反应:一项多中心研究

The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study.
PubMed 文献 · Eur Radiol · 2022-06-09

本研究回顾性纳入两个医疗中心的228例脑转移患者(训练队列184例,验证队列44例),基于治疗前MRI提取960个特征,采用LASSO筛选特征并构建结合临床因素与影像组学特征的支持向量机模型,用SHAP方法解释模型。影像组学-临床模型评估全脑放疗治疗反应的AUC在训练队列为0.928(95%CI 0.901-0.949),验证队列为0.851(95%CI 0.816-0.886)。作者认为该模型可用于评估全脑放疗治疗反应,并可能以可理解的方式辅助临床医生制定个体化全脑放疗策略。

要点

  • 影像组学-临床模型评估全脑放疗治疗反应的AUC训练队列0.928、验证队列0.851。
  • 模型由3个影像组学特征和3个临床因素构建,采用支持向量机。
  • SHAP方法可解释并可视化影像组学-临床机器学习模型。

核心结论

  • 影像组学-临床模型结合SHAP方法可用于评估全脑放疗的治疗反应,并可能以可理解的方式辅助临床医生制定个体化全脑放疗策略。

研究设计与样本

  • 回顾性纳入两个医疗中心的228例脑转移患者,训练队列184例,验证队列44例。
  • 治疗反应依据RANO-BM标准分为无反应组与有反应组。
  • 每个肿瘤从MRI序列提取960个特征,采用LASSO进行特征选择,构建结合临床因素与影像组学特征的支持向量机模型。
  • 采用SHAP方法按评估贡献对特征重要性排序以解释支持向量机模型。

诊断标准与关键数值

  • 影像组学-临床模型评估治疗反应的AUC在训练队列为0.928(95%CI 0.901-0.949),在验证队列为0.851(95%CI 0.816-0.886)。
  • 模型纳入3个影像组学特征和3个临床因素。
  • 治疗反应分组依据RANO-BM标准。

临床应用与阅片要点

  • SHAP摘要图显示特征取值影响该特征对模型的贡献,SHAP力图为单个患者的反应整合各特征的贡献。
  • 作者认为该模型可用于评估全脑放疗的治疗反应,并可能辅助临床医生制定个体化全脑放疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop and validate a pretreatment magnetic resonance imaging (MRI)-based radiomic-clinical model to assess the treatment response of whole-brain radiotherapy (WBRT) by using SHapley Additive exPlanations (SHAP), which is derived from game theory, and can explain the output of different machine learning models.

METHODS: We retrospectively enrolled 228 patients with brain metastases from two medical centers (184 in the training cohort and 44 in the validation cohort). Treatment responses of patients were categorized as a non-responding group vs. a responding group according to the Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) criteria. For each tumor, 960 features were extracted from the MRI sequence. The least absolute shrinkage and selection operator (LASSO) was used for feature selection. A support vector machine (SVM) model incorporating clinical factors and radiomic features wase used to construct the radiomic-clinical model. SHAP method explained the SVM model by prioritizing the importance of features, in terms of assessment contribution.

RESULTS: Three radiomic features and three clinical factors were identified to build the model. Radiomic-clinical model yielded AUCs of 0.928 (95%CI 0.901-0.949) and 0.851 (95%CI 0.816-0.886) for assessing the treatment response in the training cohort and validation cohort, respectively. SHAP summary plot illustrated the feature's value affected the feature's impact attributed to model, and SHAP force plot showed the integration of features' impact attributed to individual response.

CONCLUSION: The radiomic-clinical model with the SHAP method can be useful for assessing the treatment response of WBRT and may assist clinicians in directing personalized WBRT strategies in an understandable manner.

KEY POINTS: • Radiomic-clinical model can be useful for assessing the treatment response of WBRT. • SHAP could explain and visualize radiomic-clinical machine learning model in a clinician-friendly way.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Lang J, Zuo JZ, et al. The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study. Eur Radiol. 2022. PMID: 35678859. doi:10.1007/s00330-022-08887-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。